Literature DB >> 21096855

Non-negative blind source separation techniques for tumor tissue typing using HR-MAS signals.

A Croitor Sava1, D M Sima, M C Martinez-Bisbal, B Celda, S Van Huffel.   

Abstract

Given High Resolution Magic Angle Spinning (HR-MAS) signals from several glioblastoma tumor subjects, the goal is to differentiate between tumor tissue types by separating the different sources that contribute to the profile of each spectrum. Blind source separation techniques are applied for obtaining characteristic profiles for necrosis, high cellular tumor and border tumor tissue, and providing the contribution (abundance) of each tumor tissue to the profile of the spectra. The problem is formulated as a non-negative source separation problem. We illustrate the effectiveness of the proposed methods and we analyze to which extent the dimension of the input space could influence the performance by comparing the results on the full magnitude signals and on dimensionally reduced spaces.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21096855     DOI: 10.1109/IEMBS.2010.5627436

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  3 in total

Review 1.  Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.

Authors:  Christopher Dietz; Felix Ehret; Francesco Palmas; Lindsey A Vandergrift; Yanni Jiang; Vanessa Schmitt; Vera Dufner; Piet Habbel; Johannes Nowak; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

2.  Remote diffuse reflectance spectroscopy sensor for tissue engineering monitoring based on blind signal separation.

Authors:  Pedro Martín-Mateos; Sergio Crespo-Garcia; Marta Ruiz-Llata; José Ramón Lopez-Fernandez; José Luis Jorcano; Marcela Del Rio; Fernando Larcher; Pablo Acedo
Journal:  Biomed Opt Express       Date:  2014-08-28       Impact factor: 3.732

3.  A novel semi-supervised methodology for extracting tumor type-specific MRS sources in human brain data.

Authors:  Sandra Ortega-Martorell; Héctor Ruiz; Alfredo Vellido; Iván Olier; Enrique Romero; Margarida Julià-Sapé; José D Martín; Ian H Jarman; Carles Arús; Paulo J G Lisboa
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.